A California senate committee last week passed legislation (AB 290) that aims to strip the financial incentives for a third party to cover premiums for patients with end-stage renal disease. The industry-funded American Kidney Fund (AKF) says its lawyers believe the group would have to quit operations in California if the bill passes because the law would put it out of compliance with an HHS Office of Inspector General Advisory Opinion under which it has operated for more than two...